datamatters24/research-document-archive huggingface dataset:
and not based on the specific formulation or 
package size or package type), as computed (as 
of the date of publication of such drug as a se-
lected drug under section 1192(a)) in all coun-
tries described in clause (ii) of subparagraph 
(B) that are applicable countries (as described 
in clause (i) of such subparagraph) with respect 
to such drug. 
‘‘(B) APPLICABLE COUNTRIES.— 
‘‘(i) IN
GENERAL.—For purposes of 
subparagraph (A), a country described in 
clause (ii) is an applicable country de-
scribed in this clause with respect to a 
drug if there is available an average price 
for any unit for the drug for sales of such 
drug in such country. 
‘‘(ii) COUNTRIES
DESCRIBED.—For 
purposes of this paragraph, the following 
are countries described in this clause: 
‘‘(I) Australia. 
‘‘(II) Canada. 
‘‘(III) France. 
‘‘(IV) Germany. 
‘‘(V) Japan. 
‘‘(VI) The United Kingdom. 
VerDate Sep 11 2014 
04:12 Apr 27, 2021
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H3.IH
H3
pbinns on DSKJLVW7X2PROD with BILLS
under the preceding sentence shall apply to periods 
after May 8, 2014. 
(2) EXECUTIVE OFFICERS AND SENIOR MAN-
AGEMENT.—The regulations prescribed under para-
graph (1) shall provide that the management and 
control of an expanded affiliated group shall be 
treated as occurring, directly or indirectly, primarily 
within the United States if substantially all of the 
executive officers and senior management of the ex-
panded affiliated group who exercise day-to-day re-
sponsibility for making decisions involving strategic, 
financial, and operational policies of the expanded 
affiliated group are based or primarily located within 
the United States. Individuals who in fact exercise 
such day-to-day responsibilities shall be treated as 
executive officers and senior management regardless 
of their title. 
Æ 
VerDate Sep 11 2014 
21:25 Jul 20, 2021
Jkt 019200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6301
E:\BILLS\H3987.IH
H3987
pamtmann on DSKBC07HB2PROD with BILLS
I 
117TH CONGRESS 
1ST SESSION H. R. 3989 
To amend the consumer product safety laws to repeal the exclusion of pistols, 
revolvers, and other firearms from the definition of consumer product 
under such laws. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 17, 2021 
Mrs. DINGELL introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To amend the consumer product safety laws to repeal the 
exclusion of pistols, revolvers, and other firearms from 
the definition of consumer product under such laws. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Defective Firearms 
Protection Act’’. 
VerDate Sep 11 2014 
21:12 Jul 26, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3989.IH
H3989
pbinns on DSKJLVW7X2PROD with BILLS
SEC. 2. REPEAL OF EXCLUSION OF PISTOLS, REVOLVERS, 
AND OTHER FIREARMS. 
(a) DEFINITION OF CONSUMER PRODUCT.—Section 
3(a)(5) of the Consumer Product Safety Act (15 U.S.C. 
2052(a)(5)) is amended by striking subparagraph (E). 
(b) RULEMAKING AUTHORITY.—Section 3 of the 
Consumer Product Safety Commission Improvements Act 
of 1976 (15 U.S.C. 2079) is amended by striking sub-
section (e) and redesignating subsection (f) as subsection 
(e). 
Æ 
VerDate Sep 11 2014 
21:12 Jul 26, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3989.IH
H3989
pbinns on DSKJLVW7X2PROD with BILLS
I 
117TH CONGRESS 
1ST SESSION 
H. R. 398 
To amend the Immigration and Nationality Act to provide that an alien 
who has been convicted of a crime is ineligible for asylum, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 21, 2021 
Mr. GOOD of Virginia (for himself, Mr. GAETZ, Mr. DUNCAN, Mr. GOSAR, Mr. 
BROOKS, Mr. BABIN, Mr. GOODEN of Texas, Mr. TIFFANY, Mr. BIGGS, 
Mr. MOORE of Alabama, Mr. ARRINGTON, Mr. GROTHMAN, and Mr. RICE 
of South Carolina) introduced the following bill; which was referred to the 
Committee on the Judiciary 
A BILL 
To amend the Immigration and Nationality Act to provide 
that an alien who has been convicted of a crime is 
ineligible for asylum, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘No Asylum for Crimi-
nals Act of 2021’’. 
VerDate Sep 11 2014 
00:34 Feb 08, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H398.IH
H398
pbinns on DSKJLVW7X2PROD with BILLS
SEC. 2. ALIENS CONVICTED OF CRIMES INELIGIBLE FOR 
ASYLUM. 
Clause (ii) of section 208(b)(2) of the Immigration 
and Nationality Act (8 U.S.C. 1158) is amended— 
(1) by amending clause (ii) of subparagraph (A) 
to read as follows: 
‘‘(ii) except as provided in subpara-
graph (B), the alien has been finally con-
victed of a crime;’’; and 
(2) by amending subparagraph (B) to read as 
follows: 
‘‘(B) 
EXCEPTION.—The 
Secretary 
of 
Homeland Security may designate by regulation 
political offenses committed outside the United 
States that will be not considered to be a crime 
described in clause (ii). The authority under 
this subparagraph is limited to political offenses 
committed outside the United States.’’. 
Æ 
VerDate Sep 11 2014 
00:34 Feb 08, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H398.IH
H398
pbinns on DSKJLVW7X2PROD with BILLS
I 
117TH CONGRESS 
1ST SESSION H. R. 3990 
To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl 
substances in cosmetics. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 17, 2021 
Mrs. DINGELL (for herself, Ms. KUSTER, Mr. FITZPATRICK, and Mr. KATKO) 
introduced the following bill; which was referred to the Committee on En-
ergy and Commerce 
A BILL 
To ban the use of intentionally added perfluoroalkyl or 
polyfluoroalkyl substances in cosmetics. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘No PFAS in Cosmetics 
Act’’. 
SEC. 2. BAN ON PERFLUOROALKYL OR POLYFLUOROALKYL 
SUBSTANCES. 
(a) DIRECTED RULEMAKING.—Not later than 270 
days after the date of enactment of this Act, the Secretary 
of Health and Human Services (referred to in this section 
VerDate Sep 11 2014 
03:55 Jul 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3990.IH
H3990
kjohnson on DSK79L0C42PROD with BILLS
rebatable drug for an applicable year, subject to sub-
paragraphs (A) and (D) of paragraph (5), is— 
‘‘(A) the benchmark year manufacturer 
price determined under paragraph (4) for such 
dosage form and strength with respect to such 
drug and an applicable year; increased by 
‘‘(B) the percentage by which the applica-
ble year CPI–U (as defined in subsection 
(h)(5)) for the applicable year exceeds the 
benchmark period CPI–U (as defined in sub-
section (h)(4)). 
‘‘(4) DETERMINATION
OF
BENCHMARK
YEAR 
MANUFACTURER PRICE.—The benchmark year man-
ufacturer price determined under this paragraph for 
a dosage form and strength, with respect to a part 
D rebatable drug and an applicable year, is the sum 
of the products of— 
‘‘(A) the average manufacturer price (as 
defined in subsection (h)(6)) of such dosage 
form and strength, as calculated for a unit of 
such drug, with respect to each of the calendar 
quarters of the payment amount benchmark 
year (as defined in subsection (h)(3)); and 
‘‘(B) the ratio of— 
VerDate Sep 11 2014 
04:12 Apr 27, 2021
Jkt 019200
PO 00000
Frm 00093
Fmt 6652
Sfmt 6201
E:\BILLS\H3.IH
H3
pbinns on DSKJLVW7X2PROD with BILLS
as the ‘‘Secretary’’) shall issue a proposed rule to ban the 
use of intentionally added perfluoroalkyl or polyfluoroalkyl 
substances in cosmetics. Not later than 90 days after 
issuing the proposed rule, the Secretary shall finalize such 
rule. 
(b) DEFINITION.—In this section, the term ‘‘perfluo-
roalkyl or polyfluoroalkyl substance’’ means a perfluoroal-
kyl or polyfluoroalkyl substance that is man-made and has 
at least 1 fully fluorinated carbon atom. 
Æ 
VerDate Sep 11 2014 
03:55 Jul 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3990.IH
H3990
kjohnson on DSK79L0C42PROD with BILLS
I 
117TH CONGRESS 
2D SESSION 
H. R. 7026 
To amend the Food and Nutrition Act of 2008 to require States to include 
a photograph on electronic benefit cards issued to provide supplemental 
nutrition assistance program benefits. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 9, 2022 
Mr. GROTHMAN introduced the following bill; which was referred to the 
Committee on Agriculture 
A BILL 
To amend the Food and Nutrition Act of 2008 to require 
States to include a photograph on electronic benefit cards 
issued to provide supplemental nutrition assistance pro-
gram benefits. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘ID for EBT Act of 
2022’’. 
SEC. 2. AMENDMENTS. 
Section 7(h)(9) of the Food and Nutrition Act of 
2008 (7 U.S.C. 2016(h)(9)) is amended— 
VerDate Sep 11 2014 
21:36 Mar 13, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7026.IH
H7026
kjohnson on DSK79L0C42PROD with BILLS
(1) in the heading by striking ‘‘OPTIONAL’’ and 
inserting ‘‘MANDATORY’’; 
(2) in subparagraph (A) by striking ‘‘may’’ and 
inserting ‘‘shall’’; and 
(3) in subparagraph (B) by striking ‘‘If’’ and 
all that follows through ‘‘(A), the’’ and inserting 
‘‘The’’. 
SEC. 3. EFFECTIVE DATE. 
This Act and the amendments made by this Act shall 
take effect 180 days after the date of the enactment of 
this Act. 
Æ 
VerDate Sep 11 2014 
21:36 Mar 13, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H7026.IH
H7026
kjohnson on DSK79L0C42PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Protect Older Job Ap-
plicants Act of 2021’’ or ‘‘POJA Act of 2021’’. 
SEC. 2. PROHIBITION AGAINST LIMITING, SEGREGATING, 
OR CLASSIFYING APPLICANTS FOR EMPLOY-
MENT. 
Section 4(a)(2) of the Age Discrimination in Employ-
ment Act of 1967 (29 U.S.C. 623(a)(2)) is amended— 
(1) by inserting ‘‘or applicants for employment’’ 
after ‘‘employees’’; and 
(2) by inserting ‘‘or as an applicant for employ-
ment’’ after ‘‘employee’’. 
SEC. 3. STUDY. 
Not later than 1 year after the date of the enactment 
of this Act, the Equal Employment Opportunity Commis-
sion shall conduct a study to determine the number of 
claims pending or filed with the Commission since 2015 
under the Age Discrimination in Employment Act of 1967 
(29 U.S.C. 621 et seq.), including claims in closed cases, 
by job applicants who may have been adversely impacted 
by age discrimination in the job application process. The 
Chairman of the Commission shall submit to the Com-
mittee on Education and Labor of the House of Rep-
resentatives and the Committee on Health, Education, 
Labor, and Pensions of the Senate, and shall make avail-
able to the public, a report that contains the results of
the study, including recommendations for best practices 
to prevent, combat, and address age discrimination in the 
hiring process. 
Passed the House of Representatives November 4, 
2021. 
Attest: 
Clerk.
117TH CONGRESS 
1ST SESSION 
H. R. 3992 
AN ACT 
To amend the Age Discrimination in Employment 
Act of 1967 to prohibit employers from limiting, 
segregating, or classifying applicants for employ-
ment.
I 
117TH CONGRESS 
1ST SESSION H. R. 3992 
To amend the Age Discrimination in Employment Act of 1967 to prohibit 
employers from limiting, segregating, or classifying applicants for employment. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 17, 2021 
Ms. GARCIA of Texas introduced the following bill; which was referred to the 
Committee on Education and Labor 
A BILL 
To amend the Age Discrimination in Employment Act of 
1967 to prohibit employers from limiting, segregating, 
or classifying applicants for employment. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Protect Older Job Ap-
plicants Act’’ or the ‘‘POJA Act’’. 
SEC. 2. PROHIBITION AGAINST LIMITING, SEGREGATING, 
OR CLASSIFYING APPLICANTS FOR EMPLOY-
MENT. 
Section 4(a)(2) of the Age Discrimination in Employ-
ment Act of 1967 (29 U.S.C. 623(a)(2)) is amended— 
VerDate Sep 11 2014 
17:10 Jul 12, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3992.IH
H3992
pamtmann on DSKBC07HB2PROD with BILLS
(1) by inserting ‘‘or applicants for employment’’ 
after ‘‘employees’’; and 
(2) by inserting ‘‘or as an applicant for employ-
ment’’ after ‘‘employee’’. 
Æ 
VerDate Sep 11 2014 
17:10 Jul 12, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3992.IH
H3992
pamtmann on DSKBC07HB2PROD with BILLS
IIB 
117TH CONGRESS 
1ST SESSION H. R. 3992 
IN THE SENATE OF THE UNITED STATES 
NOVEMBER 15, 2021 
Received; read twice and referred to the Committee on Health, Education, 
Labor, and Pensions 
AN ACT 
To amend the Age Discrimination in Employment Act of 
1967 to prohibit employers from limiting, segregating, 
or classifying applicants for employment. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
23:19 Nov 15, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3992.RFS
H3992
pamtmann on DSKBC07HB2PROD with BILLS
HR 3992 RFS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Protect Older Job Ap-
plicants Act of 2021’’ or ‘‘POJA Act of 2021’’. 
SEC. 2. PROHIBITION AGAINST LIMITING, SEGREGATING, 
OR CLASSIFYING APPLICANTS FOR EMPLOY-
MENT. 
Section 4(a)(2) of the Age Discrimination in Employ-
ment Act of 1967 (29 U.S.C. 623(a)(2)) is amended— 
(1) by inserting ‘‘or applicants for employment’’ 
after ‘‘employees’’; and 
(2) by inserting ‘‘or as an applicant for employ-
ment’’ after ‘‘employee’’. 
SEC. 3. STUDY. 
Not later than 1 year after the date of the enactment 
of this Act, the Equal Employment Opportunity Commis-
sion shall conduct a study to determine the number of 
claims pending or filed with the Commission since 2015 
under the Age Discrimination in Employment Act of 1967 
(29 U.S.C. 621 et seq.), including claims in closed cases, 
by job applicants who may have been adversely impacted 
by age discrimination in the job application process. The 
Chairman of the Commission shall submit to the Com-
mittee on Education and Labor of the House of Rep-
resentatives and the Committee on Health, Education, 
Labor, and Pensions of the Senate, and shall make avail-
able to the public, a report that contains the results of 
VerDate Sep 11 2014 
23:19 Nov 15, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3992.RFS
H3992
pamtmann on DSKBC07HB2PROD with BILLS
HR 3992 RFS
the study, including recommendations for best practices 
to prevent, combat, and address age discrimination in the 
hiring process. 
Passed the House of Representatives November 4, 
2021. 
Attest: 
CHERYL L. JOHNSON, 
Clerk. 
VerDate Sep 11 2014 
23:19 Nov 15, 2021
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3992.RFS
H3992
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(4) UNIT.—The term ‘unit’ means, with re-
spect to a drug, the lowest identifiable quantity 
(such as a capsule or tablet, milligram of molecules, 
or grams) of the drug that is dispensed. 
‘‘SEC. 1192. SELECTION OF NEGOTIATION-ELIGIBLE DRUGS 
AS SELECTED DRUGS. 
‘‘(a) IN GENERAL.—Not later than the selected drug 
publication date with respect to an initial price applica-
bility year, subject to subsection (h), the Secretary shall 
select and publish in the Federal Register a list of— 
‘‘(1)(A) with respect to an initial price applica-
bility year during 2024, at least 25 negotiation-eligi-
ble drugs described in subparagraphs (A) and (B), 
but not subparagraph (C), of subsection (d)(1) (or, 
with respect to an initial price applicability year dur-
ing such period beginning after 2024, the maximum 
number (if such number is less than 25) of such ne-
gotiation-eligible drugs for the year) with respect to 
such year; and 
‘‘(B) with respect to an initial price applica-
bility year during 2025 or a subsequent year, at 
least 50 negotiation-eligible drugs described in sub-
paragraphs (A) and (B), but not subparagraph (C), 
of subsection (d)(1) (or, with respect to an initial 
price applicability year during such period, the max-
VerDate Sep 11 2014 
04:12 Apr 27, 2021
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H3.IH
H3
pbinns on DSKJLVW7X2PROD with BILLS
I 
117TH CONGRESS 
1ST SESSION H. R. 3999 
To appropriately limit the size of the population required for urban areas 
of metropolitan statistical areas. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 17, 2021 
Mr. JOHNSON of South Dakota (for himself and Mr. O’HALLERAN) introduced 
the following bill; which was referred to the Committee on Oversight and 
Reform 
A BILL 
To appropriately limit the size of the population required 
for urban areas of metropolitan statistical areas. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Metropolitan Statis-
tical Area Preservation Act’’. 
SEC. 2. POPULATION OF URBAN AREAS. 
Section 3504 of title 44, United States Code, is 
amended by adding at the end the following: 
‘‘(l) In implementing subsection (e)(3), the Direc-
tor— 
VerDate Sep 11 2014 
01:57 Jul 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3999.IH
H3999
kjohnson on DSK79L0C42PROD with BILLS
‘‘(1) shall not establish, for purposes of desig-
nating areas as metropolitan statistical areas, or any 
successor thereto, a minimum population for the 
urban area of such a metropolitan statistical area 
that is more than 50,000; and 
‘‘(2) may, only for statistical purposes, and in 
addition to the minimum population for urban areas 
described in paragraph (1), establish other statistical 
area designations with minimum population require-
ments for urban areas that are higher than the min-
imum population for an urban area described in 
paragraph (1).’’. 
Æ 
VerDate Sep 11 2014 
01:57 Jul 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3999.IH
H3999
kjohnson on DSK79L0C42PROD with BILLS
ance coverage offered in the group or indi-
vidual market (as such terms are defined 
in section 2791 of the Public Health Serv-
ice Act) with respect to which there is in 
effect an agreement with the Secretary 
under section 1197 with respect to such se-
lected drug as so furnished or adminis-
tered. 
‘‘(2) MAXIMUM FAIR PRICE.—The term ‘max-
imum fair price’ means, with respect to a plan year 
during a price applicability period and with respect 
to a selected drug (as defined in section 1192(c)) 
with respect to such period, the price published pur-
suant to section 1195 in the Federal Register for 
such drug and year. 
‘‘(3) AVERAGE INTERNATIONAL MARKET PRICE 
DEFINED.— 
‘‘(A) IN
GENERAL.—The terms ‘average 
international market price’ and ‘AIM price’ 
mean, with respect to a drug, the average price 
(which shall be the net average price, if prac-
ticable, and volume-weighted, if practicable) for 
a unit (as defined in paragraph (4)) of the drug 
for sales of such drug (calculated across dif-
ferent dosage forms and strengths of the drug 
VerDate Sep 11 2014 
04:12 Apr 27, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H3.IH
H3
pbinns on DSKJLVW7X2PROD with BILLS
(2) BORDER
BUSINESS.—The term ‘‘border 
business’’ means an entity eligible for a loan under 
section 7(b)(2) of the Small Business Act (15 U.S.C. 
636(b)(2)) that— 
(A) has its principal office located in the 
contiguous United States; 
(B) has estimated or actual annual average 
gross receipts less than or equal to $500,000; 
and 
(C) is located within 25 miles of the 
United States border. 
Æ 
VerDate Sep 11 2014 
00:34 Feb 08, 2021
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H399.IH
H399
pbinns on DSKJLVW7X2PROD with BILLS
H. J. Res. 109 
One Hundred Eighteenth Congress 
of the 
United States of America 
AT THE SECOND SESSION 
Begun and held at the City of Washington on Wednesday, 
the third day of January, two thousand and twenty-four 
Joint Resolution 
Providing for congressional disapproval under chapter 8 of title 5, United States 
Code, of the rule submitted by the Securities and Exchange Commission relating 
to ‘‘Staff Accounting Bulletin No. 121’’. 
Resolved by the Senate and House of Representatives of the
United States of America in Congress assembled, That Congress 
disapproves the rule submitted by the Securities and Exchange 
Commission relating to ‘‘Staff Accounting Bulletin No. 121’’ (87 
Fed. Reg. 21015 (April 11, 2022) and a letter of opinion from 
the Government Accountability Office dated October 31, 2023 (which 
was printed in the Congressional Record on November 1, 2023, 
on pages S5310–5312), concluding that such Staff Accounting Bul-
letin is a rule under chapter 8 of title 5, United States Code), 
and such rule shall have no force or effect. 
Speaker of the House of Representatives. 
Vice President of the United States and
President of the Senate.
‘‘(1) DESIGNATION
OF
AN
EMPLOYEE.—The 
Secretary shall designate an employee in the Office 
of Postsecondary Education in the Department who 
shall— 
‘‘(A) receive copies of all complaints per-
taining to the protection and regulation of the 
expressive rights of students at private institu-
tions of higher education that receive funds 
under this section, including any programs 
under this title; 
‘‘(B) preserve all records of such policies 
for a period of not less than 10 years; 
‘‘(C) receive complaints from students, stu-
dent organizations, or from any other person or 
organization, that believes a private institution 
of higher education has not disclosed a policy 
pertaining to the protection and regulation of 
the expressive rights of students as required by 
this section, is enforcing a policy pertaining to 
the expressive rights of students that has not 
been disclosed as required by this section, or 
has failed to make a full policy disclosure, for 
the enforcement of speech policies, as required 
by this section; 
VerDate Sep 11 2014 
19:09 Jul 19, 2021
Jkt 019200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H4007.IH
H4007
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(D) not more than 7 days after the date 
of receipt of a complaint under subparagraph 
(C), review the complaint and request a re-
sponse from the institution; 
‘‘(E) undertake an investigation, in re-
sponse to a complaint under subparagraph (C), 
to determine whether a private institution of 
higher education has failed to disclose a policy 
pertaining to the protection and regulation of 
the expressive rights of students as required by 
this section or is enforcing a policy pertaining 
to the expressive rights of students that has not 
been disclosed as required by this section; and 
‘‘(F) determine, not later than 120 days 
after the date of receipt of a complaint, whether 
the private institution of higher education in 
question has failed to disclose a policy per-
taining to the protection and regulation of the 
expressive rights of students as required by this 
section or is enforcing a policy pertaining to the 
expressive rights of students that has not been 
disclosed as required by this section. 
‘‘(2) LOSS OF ELIGIBILITY.— 
‘‘(A) IN GENERAL.—If the Secretary deter-
mines that a private institution of higher edu-
VerDate Sep 11 2014 
19:09 Jul 19, 2021
Jkt 019200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H4007.IH
H4007
pamtmann on DSKBC07HB2PROD with BILLS